Prof. Dr. Tayfur Toptaş

Efficacy and Reliability of T-Cell–Depleted Haploidentical Stem Cell Transplantation in Hematologic Disorders: A Retrospective Study

Transplantation Proceedings, 2024

DOI 10.1016/j.transproceed.2023.11.003 PMID 38212171 Texte intégral en libre accèsSource : OpenAlex

Peripheral T-Cell Lymphoma Coexisting with Autoimmune Hemolytic Anemia: Analysis of Clinical Features

Indian Journal of Hematology and Blood Transfusion, 2024

DOI 10.1007/s12288-024-01822-x PMID 39917494 Texte intégral en libre accèsSource : OpenAlex

MM-174 Retrospective Analysis of a Weekly Carfilzomib-Dexamethasone Regimen in Relapsed/Refractory Multiple Myeloma: Single Center Experience

Clinical Lymphoma Myeloma & Leukemia, 2024

DOI 10.1016/s2152-2650(24)01649-5 Source : OpenAlex

Retrospective Analysis of a Weekly Carfilzomib-Dexamethasone Regimen in Relapsed/Refractory Multiple Myeloma: Single Center Experience

Clinical Lymphoma Myeloma & Leukemia, 2024

DOI 10.1016/s2152-2650(24)00938-8 Source : OpenAlex

P-370 Autologous Stem Cell Transplantation in Multiple Myeloma Patients with Renal Impairment: A Retrospective Analysis

Clinical Lymphoma Myeloma & Leukemia, 2024

DOI 10.1016/s2152-2650(24)02272-9 Source : OpenAlex

The predictive value of HCT-CI and CCI comorbidity indices in predicting survival and mortality before allogeneic stem cell transplantation in acute leukemia patients: A single-centre experience

Marmara medical journal, 2024

DOI 10.5472/marumj.1571254 Texte intégral en libre accèsSource : OpenAlex

Effect of inactivated and mRNA COVID-19 vaccines on thrombocytopenia in immune thrombocytopenia patients Efecto de las vacunas inactivada y de ARNm contra la COVID-19 sobre la trombocitopenia en pacientes con trombocitopenia inmunitaria

Dspace Repository (Marmara Üniversitesi), 2024

Texte intégral en libre accèsSource : OpenAlex

Efecto de las vacunas inactivada y de ARNm contra la COVID-19 sobre la trombocitopenia en pacientes con trombocitopenia inmunitaria

Vaccimonitor/VacciMonitor, 2024

Texte intégral en libre accèsSource : OpenAlex

Glofitamab in relapsed/refractory diffuse large B‐cell lymphoma: Real‐world data

Hematological Oncology, 2023

DOI 10.1002/hon.3174 PMID 37211991 31 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

Trombin jenerasyon zamanı ve endotel disfonsiyon belirteçlerinin pulmoner endarterektomi sonuçlarına etkisi

Dspace Repository (Marmara Üniversitesi), 2023

Source : OpenAlex

Comparative Efficacy and Safety of Beam and Team Conditioning Regimens for Autologous Stem Cell Transplantation in Lymphoma Patients

Transplantation Proceedings, 2023

DOI 10.1016/j.transproceed.2022.12.001 PMID 36639277 10 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

Hereditary Hyperferritinemia-Cataract Syndrome in a Family With HFE-H63D Mutation

Cureus, 2023

DOI 10.7759/cureus.36253 PMID 37069863 4 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

The role of ruxolitinib treatment in JAK-mutated Ph-like acute lymphoblastic leukemia

Annals of Hematology, 2023

DOI 10.1007/s00277-023-05456-3 PMID 37731146 2 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

PB2147: CLINICAL FACTORS DETERMINING THE SURVIVAL OF MULTIPLE MYELOMA PATIENTS WITH EXTRAMEDULLARY DISEASE: A SINGLE-CENTER EXPERIENCE

HemaSphere, 2023

DOI 10.1097/01.hs9.0000975348.60378.b8 Texte intégral en libre accèsSource : OpenAlex

PB1957: PROGNOSTIC SIGNIFICANCE OF CHRONIC LYMPHOCYTIC LEUKEMIA WITH IGHV-U IN THE ERA OF NOVEL AGNETS; REAL-LİFE DATA

HemaSphere, 2023

DOI 10.1097/01.hs9.0000974644.87663.b9 Texte intégral en libre accèsSource : OpenAlex

P1073: A NEW SCORING SYSTEM TO PREDICT SURVIVAL IN ELDERLY ADVANCED STAGE HODGKIN LYMPHOMA PATIENTS: STUDY BY TURKISH SOCIETY OF HAEMATOLOGY LYMPHOMA ACADEMY WORKING GROUP

HemaSphere, 2023

DOI 10.1097/01.hs9.0000971188.56679.1c Texte intégral en libre accèsSource : OpenAlex

PB2657: DIFFERENT TYPES OF LEUKEMIAS AND BLEEDING DISORDER DETECTED IN A TURKISH FAMILY WITH GERMLINE RUNX1 MUTATION FOR THE FIRST TIME.

HemaSphere, 2023

DOI 10.1097/01.hs9.0000977312.96979.d7 Texte intégral en libre accèsSource : OpenAlex

P-055 Clinical factors determining the survival of multiple myeloma patients with extramedullary disease: a single-center experience

Clinical Lymphoma Myeloma & Leukemia, 2023

DOI 10.1016/s2152-2650(23)01673-7 Source : OpenAlex

PROTEOZOM İNHİBİTÖRÜ VE İMMÜNOMODÜLATUAR AJANLAR DÖNEMİNDE PRİMER PLAZMA HÜCRELİ LÖSEMİ TANILI HASTALARIN SAĞKALIM SONUÇLARI: ÇOK MERKEZLİ RETROSPEKTİF BİR ANALİZ

Kocaeli Üniversitesi - AVESİS, 2023

Source : OpenAlex

Alkalen fosfataz yüksekliği ile prezente olan primeri bilinmeyen metastatik adenokarsinom: olgu sunumu

Dspace Repository (Marmara Üniversitesi), 2023

Source : OpenAlex

Glofitamab in Relapsed/Refractory Diffuse Large B Cell Lymphoma: Real World Data

Blood, 2022

DOI 10.1182/blood-2022-165385 9 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

Impact of autologous stem cell transplantation on survival outcomes in patients with peripheral T cell lymphoma.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis, 2022

DOI 10.1016/j.transci.2022.103514 PMID 35934613 Source : ORCID

Thyroid diseases in patients with active endogenous Cushing’s syndrome

Marmara Medical Journal, 2022

DOI 10.5472/marumj.1186788 Texte intégral en libre accèsSource : ORCID

Determinants of clinical course and mortality in COVID-19 patients with hematological disorders: real life data from a single center

The European Research Journal, 2022

DOI 10.18621/eurj.1000067 Texte intégral en libre accèsSource : ORCID

Akut Lenfoblastik Lösemili Hastalarda Mikafungin Profilaksisi

İstanbul Gelişim Üniversitesi Sağlık Bilimleri Dergisi, 2022

DOI 10.38079/igusabder.993158 Texte intégral en libre accèsSource : ORCID

Predictive Immune Markers for Disease Progression in Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance

Turkish journal of haematology : official journal of Turkish Society of Haematology, 2022

DOI 10.4274/tjh.galenos.2022.2022.0046 PMID 35965418 2 citations (Europe PMC) Texte intégral en libre accèsSource : Europe PMC

Investigation of typhlitis in bone marrow transplant patients in a stem cell transplant unit

Medicine, 2022

DOI 10.1097/md.0000000000030104 PMID 36042636 4 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

Patient characteristics and management practices in chronic myeloid leukemia in Turkey: reflections from an expert meeting

Expert Review of Hematology, 2022

DOI 10.1080/17474086.2022.2044779 PMID 35184657 7 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

P1179: EFFECTIVENESS OF CENTRAL NERVOUS SYSTEM PROPHYLAXIS STRATEGIES IN DIFFUSE LARGE B-CELL LYMPHOMA

HemaSphere, 2022

DOI 10.1097/01.hs9.0000847580.02155.4e Texte intégral en libre accèsSource : OpenAlex

Brentuximab vedotin consolidation therapy after autologous stem‐cell transplantation in patients with high‐risk Hodgkin lymphoma: Multicenter retrospective study

Hematological Oncology, 2021

DOI 10.1002/hon.2897 PMID 34171130 15 citations (Europe PMC) Source : OpenAlex

HL-007: Brentuximab Vedotin Consolidation Therapy after Autologous Stem-Cell Transplantation in Patients with High-Risk Hodgkin Lymphoma: Multi-Center Retrospective Study

Clinical Lymphoma Myeloma & Leukemia, 2021

DOI 10.1016/s2152-2650(21)01845-0 Source : OpenAlex

Poster: HL-007: Brentuximab Vedotin Consolidation Therapy after Autologous Stem-Cell Transplantation in Patients with High-Risk Hodgkin Lymphoma: Multi-Center Retrospective Study

Clinical Lymphoma Myeloma & Leukemia, 2021

DOI 10.1016/s2152-2650(21)01484-1 Source : OpenAlex

Brentuximab Vedotin Consolidation Therapy after Autologous Stem-Cell Transplantation in Patients with High-Risk Hodgkin Lymphoma: Multi-Center Retrospective Study

Kocaeli Üniversitesi - AVESİS, 2021

Source : OpenAlex

COVID-19 infection in patients with acute leukemia; Istanbul experience.

Europe PMC (PubMed Central), 2021

PMID 34540352 11 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

Real-life ruxolitinib experience in intermediate-risk myelofibrosis.

Blood research, 2021

DOI 10.5045/br.2021.2021101 PMID 34916339 6 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

Shoulder-Pad Sign in a Case of Amyloidosis Associated with Myeloma

Turkish journal of haematology : official journal of Turkish Society of Haematology, 2021

DOI 10.4274/tjh.galenos.2021.2021.0630 PMID 34014054 Texte intégral en libre accèsSource : Europe PMC

Serum calprotectin (S100A8/A9) levels as a new potential biomarker of treatment response in Hodgkin lymphoma

International Journal of Laboratory Hematology, 2021

DOI 10.1111/ijlh.13559 PMID 33904653 17 citations (OpenAlex) Source : OpenAlex

Severe Acute Hemolytic Transfusion Reaction Treated with Ruxolitinib and Plasma Exchange

Transfusion Medicine and Hemotherapy, 2021

DOI 10.1159/000513056 PMID 34539320 10 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

Splenectomy in İmmune Thrombocytopenia: A Retrospective Analysis of 25-Year Follow-up Data from a Tertiary Health Clinic

Indian Journal of Hematology and Blood Transfusion, 2021

DOI 10.1007/s12288-021-01467-0 PMID 35747569 2 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

APLASTİK ANEMİ HASTALARINDA ELTROMBOPAG DENEYİMİ: TÜRKİYE ÇOK MERKEZLİ GERÇEK YAŞAM VERİSİ

Kocaeli Üniversitesi - AVESİS, 2021

Source : OpenAlex

TEDAVİ NAİF VE NÜKS/REFRAKTER KLL HASTALARINDAOBİNİTUZUMAB DENEYİMİ: TÜRKİYE ÇOK MERKEZLİGERÇEK YAŞAM VERİSİ

Kocaeli Üniversitesi - AVESİS, 2021

Source : OpenAlex

Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience

Annals of Hematology, 2020

DOI 10.1007/s00277-020-04077-4 PMID 32507911 17 citations (Europe PMC) Source : OpenAlex

BRENTUXIMAB VEDOTIN CONSOLIDATION THERAPY AFTER AUTOLOGOUS STEM-CELL TRANSPLANTATION IN PATIENTS WITH HIGH-RISK HODGKIN’xxS LYMPHOMA: MULTI-CENTER REAL-LIFE EXPERIENCE

AYBU AVESIS, 2020

Source : OpenAlex

Hydroxychloroquine-Associated Thrombotic Thrombocytopenic Purpura

Turkish journal of haematology : official journal of Turkish Society of Haematology, 2020

DOI 10.4274/tjh.galenos.2020.2020.0322 PMID 32702948 6 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

Rectal colonization with multidrug-resistant gram-negative bacteria in patients with hematological malignancies: a prospective study

Expert Review of Hematology, 2020

DOI 10.1080/17474086.2020.1787145 PMID 32574123 23 citations (OpenAlex) Source : OpenAlex

Quality of Life and Symptom Burden With First- and Second-generation Tyrosine Kinase Inhibitors in Patients With Chronic-phase Chronic Myeloid Leukemia

Clinical Lymphoma Myeloma & Leukemia, 2020

DOI 10.1016/j.clml.2020.08.009 PMID 32958432 12 citations (OpenAlex) Source : OpenAlex

Publishing in Hematology Journals: A Scientometric and Economic Evaluation

Cureus, 2020

DOI 10.7759/cureus.12069 PMID 33489487 4 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

Nodüler Lenfosit Predominant Hodgkin Lenfomada Tedavi

2020

Source : OpenAlex

PS1245 NIVOLUMAB FOR RELAPSED OR REFRACTORY HODGKIN LYMPHOMA: LONG TERM RESULTS OF MULTI‐CENTER EXPERIENCE IN TURKEY

HemaSphere, 2019

DOI 10.1097/01.hs9.0000563260.18006.d6 Texte intégral en libre accèsSource : OpenAlex

Nivolumab for relapsed or refractory Hodgkin lymphoma: long term results of multi-center experience in Turkey

AYBU AVESIS, 2019

Source : OpenAlex